50 mg lyophilised · single compound
$50.00 CAD
GHK-Cu is a naturally occurring copper-bound tripeptide studied in skin and wound-healing research. Laboratory work examines its role in collagen production, tissue remodelling, and antioxidant signalling.
For laboratory and research use only - not for human consumption.
Checking the live COA archive for the newest lot documentation.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsGHK-Cu is a copper-binding tripeptide (a three-amino-acid chain: glycine-histidine-lysine) joined to a copper ion. It occurs naturally in human blood plasma and declines with age. The copper it carries is itself a cofactor for many repair enzymes.
Three decades of laboratory, animal, and some human studies have examined GHK-Cu in skin and wound-healing research - collagen and elastin production (the proteins that give skin structure and stretch), extracellular-matrix remodelling (rebuilding the scaffold around cells), and antioxidant/anti-inflammatory effects. It also appears as an ingredient in topical cosmetic formulations.
GHK-Cu is associated with switching on repair- and remodelling-related genes, delivering copper for enzyme function, and supporting the outgrowth of blood vessels and nerves in tissue-repair models.
GHK-Cu is not an approved drug; the peptide appears in topical cosmetics, but the material here is supplied as a research compound - not a cosmetic or drug, and not for human consumption. In the U.S. it is part of the FDA’s 2026-2027 peptide-compounding review (nomination withdrawn from Category 1; advisory-committee consultation expected by February 2027). This does not change its research-use status in Canada.
A single vial containing 50 mg of GHK-Cu as a lyophilised powder.
